Search Results
Found 1 results
510(k) Data Aggregation
(71 days)
HARDYDISK ERYTHROMYCIN, 15MCG
HardyDisk™ Antimicrobial Seasitivity Disks are used for semi-quantitative in vitro susceptibility testing by the agar diffusion test proccdure (Kirby-Bauer) of rapidly growing and certain fastidious bacterial vathogens. Standardized methods for agar diffusion testing have been described for Euterobacteriaccas, Staphylococcus spp., Pseudomonas spn., Acinetobacter spp., Listerta monocytogenes, Enterococcus spp., other streptococci and, hy modified procedures, Haemophilus influenzae, Neisseria gonorrhoeae and Streptococcus pneumoniae.
Hardy Disk™ Erythromycin is indicated for in vitro activity against Staphylococcus spp., and Streptococcus spp. including S. pneumoniae.
HardyDisk™ Erythromycin 15mcg is an antimicrobial sensitivity disk.
The provided text is a 510(k) premarket notification letter from the FDA to Hardy Diagnostics for their HardyDisk™ Erythromycin 15mcg. While it confirms the device's substantial equivalence to a predicate device and its regulatory classification, it does not contain the detailed study information or acceptance criteria requested.
Therefore, I cannot provide a response filling out the requested table and study details. The document is primarily a regulatory approval letter and an "Indications for Use Statement."
Ask a specific question about this device
Page 1 of 1